MiniMed (MMED) Gross Margin (2025 - 2026)
MiniMed (MMED) posted Gross Margin of 55.16% for Q3 2026, down 3.81% quarter-over-quarter from 57.35% in Q2 2026, and down 141.0% YoY from 134.54% in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Gross Margin (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Gross Margin data on file, last reported at 55.16% in Q3 2026.
- For the quarter ending Q3 2026, Gross Margin fell 141.0% year-over-year to 55.16%; the trailing twelve-month figure through Jul 2026 stood at 53.74% (changed N/A YoY), and the FY2026 full-year result was 54.16%, down 212.0% from the prior year.
- Gross Margin was 55.16% for Q3 2026 at MiniMed, down from 57.35% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 57.5% in Q1 2025 to a low of 45.82% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | 55.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 55.16% |
| Apr 24, 2026 | 57.35% |
| Jan 23, 2026 | 45.82% |
| Apr 25, 2025 | 55.94% |
| Jan 24, 2025 | 57.50% |